Source: |
Type: |
AMPK: guardian of metabolism and mitochondrial homeostasis; Upon changes in the ATP-to-AMP ratio, AMPK is activated. (AMPK) is a key metabolic sensor that is pivotal for the maintenance of cellular energy homeostasis. It is well documented that AMPK possesses a suppressor role in the context of tumor development and progression by modulating the inflammatory and metabolic pathways. -Activating AMPK can inhibit anabolic processes and the PI3K/Akt/mTOR pathway reducing glycolysis shifting toward Oxidative Phosphorlylation. AMPK activators: -metformin or AICAR -Resveratrol: activate AMPK indirectly -Berberine -Quercetin: may stimulate AMPK -EGCG: thought to activate AMPK -Curcumin: may activate AMPK -Ginsenosides: Some ginsenosides have been associated with AMPK activation -Beta-Lapachone: A natural naphthoquinone compound found in the bark of Tabebuia avellanedae (also known as lapacho or taheebo). It has been observed to activate AMPK in certain models. -Alpha-Lipoic Acid (ALA): associated with AMPK activation |
2327- | 2DG, | 2-Deoxy-d-Glucose and Its Analogs: From Diagnostic to Therapeutic Agents |
- | Review, | Var, | NA |
250- | AL, | Allicin Induces p53-Mediated Autophagy in Hep G2 Human Liver Cancer Cells |
- | in-vitro, | Liver, | HepG2 |
1069- | AL, | Allicin promotes autophagy and ferroptosis in esophageal squamous cell carcinoma by activating AMPK/mTOR signaling |
- | vitro+vivo, | ESCC, | TE1 | - | vitro+vivo, | ESCC, | KYSE-510 | - | in-vitro, | Nor, | Het-1A |
297- | ALA, | Insights on the Use of α-Lipoic Acid for Therapeutic Purposes |
- | Review, | BC, | SkBr3 | - | Review, | neuroblastoma, | SK-N-SH | - | Review, | AD, | NA |
276- | ALA, | Alpha lipoic acid diminishes migration and invasion in hepatocellular carcinoma cells through an AMPK-p53 axis |
- | in-vitro, | HCC, | HepG2 | - | in-vitro, | HCC, | Hep3B |
262- | ALA, | Lipoic acid decreases breast cancer cell proliferation by inhibiting IGF-1R via furin downregulation |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
1124- | ALA, | Alpha lipoic acid inhibits proliferation and epithelial mesenchymal transition of thyroid cancer cells |
- | in-vitro, | Thyroid, | BCPAP | - | in-vitro, | Thyroid, | HTH-83 | - | in-vitro, | Thyroid, | CAL-62 | - | in-vitro, | Thyroid, | FTC-133 | - | in-vivo, | NA, | NA |
3454- | ALA, | Lipoic acid blocks autophagic flux and impairs cellular bioenergetics in breast cancer and reduces stemness |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
3539- | ALA, | Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential |
- | Review, | AD, | NA |
3272- | ALA, | Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential |
- | Review, | AD, | NA |
1159- | And, | Andrographolide, an Anti-Inflammatory Multitarget Drug: All Roads Lead to Cellular Metabolism |
- | Review, | NA, | NA |
2583- | Api, | Rad, | The influence of apigenin on cellular responses to radiation: From protection to sensitization |
- | Review, | Var, | NA |
2318- | Api, | Apigenin as a multifaceted antifibrotic agent: Therapeutic potential across organ systems |
- | Review, | Nor, | NA |
3667- | ART/DHA, | Artemisinin improves neurocognitive deficits associated with sepsis by activating the AMPK axis in microglia |
- | Review, | Sepsis, | NA |
3396- | ART/DHA, | Progress on the study of the anticancer effects of artesunate |
- | Review, | Var, | NA |
1076- | ART/DHA, | The Potential Mechanisms by which Artemisinin and Its Derivatives Induce Ferroptosis in the Treatment of Cancer |
- | Review, | NA, | NA |
3164- | Ash, | Withaferin A alleviates fulminant hepatitis by targeting macrophage and NLRP3 |
3166- | Ash, | Exploring the Multifaceted Therapeutic Potential of Withaferin A and Its Derivatives |
- | Review, | Var, | NA |
1524- | Ba, | AMPK_in_Human_Lung_Carcinoma_A549_Cells">Baicalein Induces Caspase‐dependent Apoptosis Associated with the Generation of ROS and the Activation of AMPK in Human Lung Carcinoma A549 Cells |
- | in-vitro, | Lung, | A549 |
2047- | BA, | Sodium butyrate inhibits migration and induces AMPK-mTOR pathway-dependent autophagy and ROS-mediated apoptosis via the miR-139-5p/Bmi-1 axis in human bladder cancer cells |
- | in-vitro, | CRC, | T24 | - | in-vitro, | Nor, | SV-HUC-1 | - | in-vitro, | Bladder, | 5637 | - | in-vivo, | NA, | NA |
2626- | Ba, | Molecular targets and therapeutic potential of baicalein: a review |
- | Review, | Var, | NA | - | Review, | AD, | NA | - | Review, | Stroke, | NA |
2292- | Ba, | BA, | Baicalin and baicalein in modulating tumor microenvironment for cancer treatment: A comprehensive review with future perspectives |
- | Review, | Var, | NA |
2389- | BA, | Baicalin alleviates lipid accumulation in adipocytes via inducing metabolic reprogramming and targeting Adenosine A1 receptor |
- | in-vitro, | Obesity, | 3T3 |
2476- | Ba, | Baicalein Induces Caspase-dependent Apoptosis Associated with the Generation of ROS and the Activation of AMPK in Human Lung Carcinoma A549 Cells |
- | in-vitro, | Lung, | A549 |
4305- | Ba, | Study on the Molecular Mechanism of Baicalin Phosphorylation of Tau Protein Content in a Cell Model of Intervention Cognitive Impairment |
- | in-vitro, | NA, | SH-SY5Y |
1395- | BBR, | Analysis of the mechanism of berberine against stomach carcinoma based on network pharmacology and experimental validation |
- | in-vitro, | GC, | NA |
2696- | BBR, | Berberine regulates proliferation, collagen synthesis and cytokine secretion of cardiac fibroblasts via AMPK-mTOR-p70S6K signaling pathway |
- | in-vivo, | Nor, | NA |
2698- | BBR, | A gene expression signature-based approach reveals the mechanisms of action of the Chinese herbal medicine berberine |
- | Analysis, | BC, | MDA-MB-231 |
2714- | BBR, | Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer |
- | in-vivo, | Diabetic, | NA |
2674- | BBR, | Berberine: A novel therapeutic strategy for cancer |
- | Review, | Var, | NA | - | Review, | IBD, | NA |
2677- | BBR, | Liposome-Encapsulated Berberine Alleviates Liver Injury in Type 2 Diabetes via Promoting AMPK/mTOR-Mediated Autophagy and Reducing ER Stress: Morphometric and Immunohistochemical Scoring |
- | in-vivo, | Diabetic, | NA |
2686- | BBR, | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
- | Review, | Nor, | NA |
2729- | BetA, | Betulinic acid in the treatment of tumour diseases: Application and research progress |
- | Review, | Var, | NA |
2739- | BetA, | Glycolytic Switch in Response to Betulinic Acid in Non-Cancer Cells |
- | in-vitro, | Nor, | HUVECs | - | in-vitro, | Nor, | MEF |
- | Review, | Var, | NA |
2730- | BetA, | Betulinic acid induces autophagy-dependent apoptosis via Bmi-1/ROS/AMPK-mTOR-ULK1 axis in human bladder cancer cells |
- | in-vitro, | Bladder, | T24 |
3516- | Bor, | Boron in wound healing: a comprehensive investigation of its diverse mechanisms |
- | Review, | Wounds, | NA |
699- | Bor, | Boric Acid Alleviates Gastric Ulcer by Regulating Oxidative Stress and Inflammation-Related Multiple Signaling Pathways |
- | in-vivo, | NA, | NA |
1416- | Bos, | Anti-cancer properties of boswellic acids: mechanism of action as anti-cancerous agent |
- | Review, | NA, | NA |
1650- | CA, | Adjuvant Properties of Caffeic Acid in Cancer Treatment |
- | Review, | Var, | NA |
1651- | CA, | PBG, | Caffeic acid and its derivatives as potential modulators of oncogenic molecular pathways: New hope in the fight against cancer |
- | Review, | Var, | NA |
- | in-vitro, | Cerv, | SiHa |
1263- | CAP, | Capsaicin inhibits the migration and invasion via the AMPK/NF-κB signaling pathway in esophagus sequamous cell carcinoma by decreasing matrix metalloproteinase-9 expression |
- | in-vitro, | ESCC, | Eca109 |
2017- | CAP, | Spice Up Your Kidney: A Review on the Effects of Capsaicin in Renal Physiology and Disease |
- | Review, | Var, | NA |
2012- | CAP, | Capsaicin induces cytotoxicity in human osteosarcoma MG63 cells through TRPV1-dependent and -independent pathways |
- | NA, | OS, | MG63 |
2348- | CAP, | Recent advances in analysis of capsaicin and its effects on metabolic pathways by mass spectrometry |
- | Analysis, | Nor, | NA |
2653- | Cela, | Oxidative Stress Inducers in Cancer Therapy: Preclinical and Clinical Evidence |
- | Review, | Var, | NA |
1145- | CHr, | Chrysin inhibits propagation of HeLa cells by attenuating cell survival and inducing apoptotic pathways |
- | in-vitro, | Cerv, | HeLa |
2801- | CHr, | AMP-activated protein kinase (AMPK) activation is involved in chrysin-induced growth inhibition and apoptosis in cultured A549 lung cancer cells |
- | in-vitro, | Lung, | A549 |
2780- | CHr, | Anti-cancer Activity of Chrysin in Cancer Therapy: a Systematic Review |
- | Review, | Var, | NA |
168- | CUR, | Curcumin inhibits Akt/mammalian target of rapamycin signaling through protein phosphatase-dependent mechanism |
- | in-vitro, | Pca, | PC3 |
445- | CUR, | Curcumin Regulates the Progression of Colorectal Cancer via LncRNA NBR2/AMPK Pathway |
- | in-vitro, | CRC, | HCT116 | - | in-vitro, | CRC, | HCT8 | - | in-vitro, | CRC, | SW480 | - | in-vitro, | CRC, | SW-620 |
3795- | CUR, | Curcumin: A Golden Approach to Healthy Aging: A Systematic Review of the Evidence |
- | Review, | AD, | NA |
19- | Deg, | Deguelin inhibits proliferation and migration of human pancreatic cancer cells in vitro targeting hedgehog pathway |
- | in-vitro, | PC, | Bxpc-3 | - | in-vitro, | PC, | PANC1 |
951- | DHA, | Docosahexaenoic Acid Attenuates Breast Cancer Cell Metabolism and the Warburg Phenotype by Targeting Bioenergetic Function |
- | in-vitro, | BC, | BT474 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | Nor, | MCF10 |
1854- | dietFMD, | How Far Are We from Prescribing Fasting as Anticancer Medicine? |
- | Review, | Var, | NA |
1844- | dietFMD, | Unlocking the Potential: Caloric Restriction, Caloric Restriction Mimetics, and Their Impact on Cancer Prevention and Treatment |
- | Review, | NA, | NA |
1626- | dietSTF, | dietFMD, | When less may be more: calorie restriction and response to cancer therapy |
- | Review, | Var, | NA |
3708- | dietSTF, | Fasting as a Therapy in Neurological Disease |
1621- | EA, | The multifaceted mechanisms of ellagic acid in the treatment of tumors: State-of-the-art |
- | Review, | Var, | NA |
651- | EGCG, | Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications |
665- | EGCG, | Anticancer effects of epigallocatechin-3-gallate nanoemulsion on lung cancer cells through the activation of AMP-activated protein kinase signaling pathway |
- | in-vitro, | NA, | H1299 |
683- | EGCG, | Targeting the AMP-Activated Protein Kinase for Cancer Prevention and Therapy |
- | Review, | NA, | NA |
3244- | EGCG, | Novel epigallocatechin gallate (EGCG) analogs activate AMP-activated protein kinase pathway and target cancer stem cells |
3214- | EGCG, | EGCG-induced selective death of cancer cells through autophagy-dependent regulation of the p62-mediated antioxidant survival pathway |
- | in-vitro, | Nor, | MRC-5 | - | in-vitro, | Cerv, | HeLa | - | in-vitro, | Nor, | HEK293 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | CRC, | HCT116 |
2845- | FIS, | Fisetin: A bioactive phytochemical with potential for cancer prevention and pharmacotherapy |
- | Review, | Var, | NA |
2849- | FIS, | Activation of reactive oxygen species/AMP activated protein kinase signaling mediates fisetin-induced apoptosis in multiple myeloma U266 cells |
- | in-vitro, | Melanoma, | U266 |
2860- | FIS, | Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways |
- | in-vitro, | PC, | PANC1 | - | in-vitro, | PC, | Bxpc-3 | - | in-vitro, | Nor, | hTERT-HPNE | - | in-vivo, | NA, | NA |
2825- | FIS, | Exploring the molecular targets of dietary flavonoid fisetin in cancer |
- | Review, | Var, | NA |
2832- | FIS, | Fisetin's Promising Antitumor Effects: Uncovering Mechanisms and Targeting for Future Therapies |
- | Review, | Var, | NA |
1186- | Gb, | Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis |
- | in-vitro, | PC, | NA | - | in-vitro, | Nor, | HUVECs | - | in-vivo, | PC, | NA |
3776- | H2, | The role of hydrogen in Alzheimer's disease |
- | Review, | AD, | NA |
3774- | H2, | The role of hydrogen in Alzheimer’s disease |
- | Review, | AD, | NA |
3773- | H2, | Role and mechanism of molecular hydrogen in the treatment of Parkinson’s diseases |
- | Review, | Park, | NA |
3766- | H2, | The role of hydrogen in Alzheimer′s disease |
- | Review, | AD, | NA |
3767- | H2, | The role of hydrogen therapy in Alzheimer's disease management: Insights into mechanisms, administration routes, and future challenges |
- | Review, | AD, | NA |
292- | HCA, | Hydroxycitric Acid Inhibits Chronic Myelogenous Leukemia Growth through Activation of AMPK and mTOR Pathway |
- | in-vitro, | AML, | K562 |
2879- | HNK, | Honokiol Inhibits Lung Tumorigenesis through Inhibition of Mitochondrial Function |
- | in-vitro, | Lung, | H226 | - | in-vivo, | NA, | NA |
2864- | HNK, | Honokiol: A Review of Its Anticancer Potential and Mechanisms |
- | Review, | Var, | NA |
1918- | JG, | ROS -mediated p53 activation by juglone enhances apoptosis and autophagy in vivo and in vitro |
- | in-vitro, | Liver, | HepG2 | - | in-vivo, | NA, | NA |
2921- | LT, | Luteolin as a potential hepatoprotective drug: Molecular mechanisms and treatment strategies |
- | Review, | Nor, | NA |
4338- | LT, | Luteolin: a natural product with multiple mechanisms for atherosclerosis |
- | Review, | NA, | NA |
3265- | Lyco, | Lycopene inhibits pyroptosis of endothelial progenitor cells induced by ox-LDL through the AMPK/mTOR/NLRP3 pathway |
- | in-vitro, | Nor, | NA |
2545- | M-Blu, | Reversing the Warburg Effect as a Treatment for Glioblastoma |
- | in-vitro, | GBM, | U87MG | - | NA, | AD, | NA | - | in-vitro, | GBM, | A172 | - | in-vitro, | GBM, | T98G |
2540- | M-Blu, | Alternative mitochondrial electron transfer for the treatment of neurodegenerative diseases and cancers: Methylene blue connects the dots |
- | Review, | Var, | NA | - | Review, | AD, | NA |
994- | MET, | Tumor metabolism destruction via metformin-based glycolysis inhibition and glucose oxidase-mediated glucose deprivation for enhanced cancer therapy |
- | in-vitro, | Var, | NA |
970- | MET, | Metformin suppresses HIF-1α expression in cancer-associated fibroblasts to prevent tumor-stromal cross talk in breast cancer |
2456- | MET, | Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer |
- | in-vitro, | BC, | MDA-MB-231 | - | in-vivo, | NA, | NA |
2492- | MET, | The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective |
- | Review, | Nor, | NA |
2386- | MET, | Mechanisms of metformin inhibiting cancer invasion and migration |
- | Review, | Var, | NA |
2383- | MET, | Activation of AMPK by metformin promotes renal cancer cell proliferation under glucose deprivation through its interaction with PKM2 |
- | in-vitro, | RCC, | A498 |
2379- | MET, | Down‐regulation of PKM2 enhances anticancer efficiency of THP on bladder cancer |
- | in-vitro, | Bladder, | T24 | - | in-vitro, | BC, | UMUC3 |
2377- | MET, | Metformin Inhibits TGF-β1-Induced Epithelial-to-Mesenchymal Transition via PKM2 Relative-mTOR/p70s6k Signaling Pathway in Cervical Carcinoma Cells |
- | in-vitro, | Cerv, | HeLa | - | in-vitro, | Cerv, | SiHa |
3499- | MFrot, | MF, | Rotating magnetic field delays human umbilical vein endothelial cell aging and prolongs the lifespan of Caenorhabditis elegans |
- | in-vitro, | Nor, | HUVECs |
2937- | NAD, | High-Dosage NMN Promotes Ferroptosis to Suppress Lung Adenocarcinoma Growth through the NAM-Mediated SIRT1-AMPK-ACC Pathway |
- | in-vitro, | Lung, | A549 |
3587- | PI, | Piperine: A review of its biological effects |
- | Review, | Park, | NA | - | Review, | AD, | NA |
1237- | PTS, | Pterostilbene induces cell apoptosis and inhibits lipogenesis in SKOV3 ovarian cancer cells by activation of AMPK-induced inhibition of Akt/mTOR signaling cascade |
- | in-vitro, | Ovarian, | SKOV3 |
3381- | QC, | Quercetin induces cell death in cervical cancer by reducing O-GlcNAcylation of adenosine monophosphate-activated protein kinase |
- | in-vitro, | Cerv, | HeLa |
3365- | QC, | Quercetin attenuates sepsis-induced acute lung injury via suppressing oxidative stress-mediated ER stress through activation of SIRT1/AMPK pathways |
- | in-vivo, | Sepsis, | NA |
3336- | QC, | Neuroprotective Effects of Quercetin in Alzheimer’s Disease |
- | Review, | AD, | NA |
4297- | QC, | Quercetin attenuates tau hyperphosphorylation and improves cognitive disorder via suppression of ER stress in a manner dependent on AMPK pathway |
- | in-vitro, | AD, | SH-SY5Y |
2332- | RES, | Resveratrol’s Anti-Cancer Effects through the Modulation of Tumor Glucose Metabolism |
- | Review, | Var, | NA |
2443- | RES, | Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review |
- | Review, | Var, | NA |
2566- | RES, | A comprehensive review on the neuroprotective potential of resveratrol in ischemic stroke |
- | Review, | Stroke, | NA |
3069- | RES, | Resveratrol Inhibits NLRP3 Inflammasome-Induced Pyroptosis and miR-155 Expression in Microglia Through Sirt1/AMPK Pathway |
- | in-vitro, | Nor, | N9 |
3080- | RES, | Resveratrol: A miraculous natural compound for diseases treatment |
- | Review, | Var, | NA |
3056- | RES, | Less is more for cancer chemoprevention: evidence of a non-linear dose response for the protective effects of resveratrol in humans and mice |
- | in-vivo, | Nor, | NA |
3100- | RES, | Neuroprotective effects of resveratrol in Alzheimer disease pathology |
- | Review, | AD, | NA |
3099- | RES, | Resveratrol and cognitive decline: a clinician perspective |
- | Review, | Nor, | NA | - | NA, | AD, | NA |
2687- | RES, | Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs |
- | Review, | NA, | NA | - | Review, | AD, | NA |
3612- | RES, | Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential |
- | Review, | AD, | NA |
4284- | RES, | Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex |
- | in-vitro, | AD, | HEK293 | - | NA, | Stroke, | NA | - | in-vivo, | AD, | NA |
4286- | RES, | Neuroprotective Properties of Resveratrol and Its Derivatives—Influence on Potential Mechanisms Leading to the Development of Alzheimer’s Disease |
- | Review, | AD, | NA |
4288- | RES, | Trans-resveratrol Inhibits Tau Phosphorylation in the Brains of Control and Cadmium Chloride-Treated Rats by Activating PP2A and PI3K/Akt Induced-Inhibition of GSK3β |
- | in-vivo, | AD, | NA |
1745- | RosA, | Rosmarinic acid and its derivatives: Current insights on anticancer potential and other biomedical applications |
- | Review, | Var, | NA | - | Review, | AD, | NA |
1723- | SFN, | Sulforaphane as a potential remedy against cancer: Comprehensive mechanistic review |
- | Review, | Var, | NA |
1471- | SFN, | ROS-mediated activation of AMPK plays a critical role in sulforaphane-induced apoptosis and mitotic arrest in AGS human gastric cancer cells |
- | in-vitro, | GC, | AGS |
- | in-vitro, | CRC, | HCT116 |
3186- | SFN, | A pharmacological inhibitor of NLRP3 inflammasome prevents non-alcoholic fatty liver disease in a mouse model induced by high fat diet |
- | in-vivo, | Nor, | NA |
2445- | SFN, | Sulforaphane-Induced Cell Cycle Arrest and Senescence are accompanied by DNA Hypomethylation and Changes in microRNA Profile in Breast Cancer Cells |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | SkBr3 |
3319- | SIL, | Silymarin and neurodegenerative diseases: Therapeutic potential and basic molecular mechanisms |
- | Review, | AD, | NA | - | Review, | Park, | NA | - | Review, | Stroke, | NA |
2232- | SK, | Shikonin Induces Autophagy and Apoptosis in Esophageal Cancer EC9706 Cells by Regulating the AMPK/mTOR/ULK Axis |
- | in-vitro, | ESCC, | EC9706 |
2218- | SK, | Shikonin Alleviates Endothelial Cell Injury Induced by ox-LDL via AMPK/Nrf2/HO-1 Signaling Pathway |
- | in-vitro, | Nor, | HUVECs |
1193- | SM, | Cryptotanshinone from the Salvia miltiorrhiza Bunge Attenuates Ethanol-Induced Liver Injury by Activation of AMPK/SIRT1 and Nrf2 Signaling Pathways |
- | in-vivo, | Alcohol, | NA | - | in-vitro, | Liver, | HepG2 |
3427- | TQ, | Chemopreventive and Anticancer Effects of Thymoquinone: Cellular and Molecular Targets |
3401- | TQ, | Molecular mechanisms and signaling pathways of black cumin (Nigella sativa) and its active constituent, thymoquinone: a review |
- | Review, | Var, | NA |
2411- | UA, | Ursolic acid in health and disease |
- | Review, | Var, | NA |
2350- | UA, | Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells |
- | in-vitro, | BC, | MCF-7 | - | in-vitro, | BC, | MDA-MB-231 |
119- | UA, | CUR, | RES, | Combinatorial treatment with natural compounds in prostate cancer inhibits prostate tumor growth and leads to key modulations of cancer cell metabolism |
- | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | PC3 |
3141- | VitC, | High-dose Vitamin C inhibits PD-L1 expression by activating AMPK in colorectal cancer |
- | in-vitro, | CRC, | HCT116 |
2366- | VitD3, | Vitamin D3 decreases glycolysis and invasiveness, and increases cellular stiffness in breast cancer cells |
- | in-vitro, | BC, | MCF-7 |
1818- | VitK2, | New insights on vitamin K biology with relevance to cancer |
- | Review, | Var, | NA |
1214- | VitK2, | Vitamin K2 promotes PI3K/AKT/HIF-1α-mediated glycolysis that leads to AMPK-dependent autophagic cell death in bladder cancer cells |
- | in-vitro, | Bladder, | T24 | - | in-vitro, | Bladder, | J82 |
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:9 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid